Monopril (Fosinopril Sodium)

Fosinopril, the active ingredient in Monopril, is a Angiotensin-Converting Enzyme (ACE) Inhibitor presented as a [strength]/[form] for oral use. It treats hypertension and heart failure in adult patients, helping to lower blood pressure and improve cardiac function.

GNH USA supplies Monopril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards and is manufactured under GMP conditions. Our distribution network ensures reliable delivery to healthcare providers across multiple regions.

Monopril (fosinopril) is an ACE inhibitor used in cardiovascular disease management.

- Hypertension: lowers systemic blood pressure by reducing angiotensin II‑mediated vasoconstriction. - Heart failure: improves ventricular function and reduces symptoms such as dyspnea and edema. - Post‑myocardial infarction: decreases the risk of subsequent cardiovascular events and supports cardiac remodeling.

Fosinopril may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Cough: persistent dry cough in many patients. - Dizziness: especially upon standing or dose changes. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Nausea: occasional upset stomach. - Taste disturbance: altered or metallic taste.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway requiring immediate medical attention. - Severe hypotension: marked drop in blood pressure, potentially causing fainting. - Renal impairment: sudden rise in serum creatinine or reduced kidney function. - Hepatotoxicity: elevated liver enzymes indicating liver injury. - Anaphylactoid reactions: rare severe allergic responses.

When prescribing Monopril, clinicians should observe several precautionary measures to ensure patient safety.

- Blood pressure monitoring: check regularly after initiation and dose adjustments. - Renal function assessment: evaluate serum creatinine and eGFR before and during therapy. - Serum potassium monitoring: avoid hyperkalaemia, especially with potassium‑sparing agents. - Pregnancy contraindication: avoid use during pregnancy due to potential fetal harm. - Dose adjustment in hepatic impairment: use lower initial doses and titrate cautiously. - Store at room temperature: keep in original container, protect from moisture and light.

Fosinopril can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): combined use may increase risk of renal impairment, hyperkalaemia, and hypotension. - Lithium: fosinopril may raise lithium levels, leading to toxicity. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalaemia.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may blunt antihypertensive effect and impair renal function. - Thiazide diuretics: additive blood‑pressure lowering effect; monitor for hypotension.